Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Tosilate for Sedation in Upper Gastrointestinal Endoscopy
NCT06169995Phase 4Completed
- Sponsor
- Hengrui
- Start
- Dec 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam in Procedural sedation (PS), sponsored by Hengrui. Primary endpoint: Percentage of participants who experienced successful sedation at Day 1. Started Dec 2023; status: completed.
02
Drugs
remimazolam
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT06169995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06169995.